Bromoacetamido-PEG4-NHS ester
Code | Size | Price |
---|
TAR-T14825-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14825-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Bromoacetamido-PEG4-NHS ester is a PEGylated N-hydroxysuccinimide ester compound, specifically designed as a linker for PROTAC synthesis. This PEG-based PROTAC linker, when utilized, facilitates the creation of protein-targeted chimeras (PROTACs)[1].
CAS:
1260139-70-5
Formula:
C17H27BrN2O9
Molecular Weight:
483.31
Purity:
0.98
SMILES:
O=C(ON1C(=O)CCC1=O)CCOCCOCCOCCOCCNC(=O)CBr
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562